BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31693987)

  • 21. Management trends in stage I testicular seminoma: Impact of race, insurance status, and treatment facility.
    Gray PJ; Lin CC; Sineshaw H; Paly JJ; Jemal A; Efstathiou JA
    Cancer; 2015 Mar; 121(5):681-7. PubMed ID: 25345675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores.
    Chen J; Wu X; Christos PJ; Formenti S; Nagar H
    Breast Cancer Res; 2018 Apr; 20(1):26. PubMed ID: 29661221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.
    Lin CC; Bruinooge SS; Kirkwood MK; Olsen C; Jemal A; Bajorin D; Giordano SH; Goldstein M; Guadagnolo BA; Kosty M; Hopkins S; Yu JB; Arnone A; Hanley A; Stevens S; Hershman DL
    J Clin Oncol; 2015 Oct; 33(28):3177-85. PubMed ID: 26304878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer.
    Felder TM; Do DP; Lu ZK; Lal LS; Heiney SP; Bennett CL
    Breast Cancer Res Treat; 2016 May; 157(1):193-200. PubMed ID: 27120468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer.
    Muralidhar V; Mahal BA; Rose BS; Chen YW; Nezolosky MD; Efstathiou JA; Beard CJ; Martin NE; Orio PF; Trinh QD; Choueiri TK; Sweeney CJ; Nguyen PL
    Clin Genitourin Cancer; 2017 Oct; 15(5):563-569.e3. PubMed ID: 28462857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity.
    Swords DS; Mulvihill SJ; Brooke BS; Skarda DE; Firpo MA; Scaife CL
    Surgery; 2019 Apr; 165(4):751-759. PubMed ID: 30551868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer.
    Ma SJ; Oladeru OT; Miccio JA; Iovoli AJ; Hermann GM; Singh AK
    JAMA Netw Open; 2019 Aug; 2(8):e199126. PubMed ID: 31411712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A national evaluation of adjuvant chemotherapy in pT4N0M0 colon cancer from the National Cancer Database.
    Reif de Paula T; Keller DS
    J Natl Cancer Inst; 2023 Dec; 115(12):1616-1625. PubMed ID: 37584736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
    Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
    Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disparities in Stage-Specific Guideline-Concordant Cancer-Directed Treatment for Patients with Pancreatic Adenocarcinoma.
    Hamad A; DePuccio M; Reames BN; Dave A; Kurien N; Cloyd JM; Shen C; Pawlik TM; Tsung A; McAlearney AS; Ejaz A
    J Gastrointest Surg; 2021 Nov; 25(11):2889-2901. PubMed ID: 33768427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma.
    Spitzer HV; Kemp Bohan PM; Carpenter EL; Adams AM; Chang SC; Grunkemeier G; Vreeland TJ; Tzeng CD; Katz MHG; Nelson DW
    Ann Surg Oncol; 2023 Oct; 30(11):6662-6670. PubMed ID: 37330447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy.
    Mayo SC; Gilson MM; Herman JM; Cameron JL; Nathan H; Edil BH; Choti MA; Schulick RD; Wolfgang CL; Pawlik TM
    J Am Coll Surg; 2012 Jan; 214(1):33-45. PubMed ID: 22055585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.
    McDade TP; Hill JS; Simons JP; Piperdi B; Ng SC; Zhou Z; Kadish SP; Fitzgerald TJ; Tseng JF
    Cancer; 2010 Jul; 116(13):3257-66. PubMed ID: 20564625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Colon Cancer.
    Manjelievskaia J; Brown D; McGlynn KA; Anderson W; Shriver CD; Zhu K
    JAMA Surg; 2017 May; 152(5):452-459. PubMed ID: 28122072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors related to the receipt of adjuvant therapy among patients with gastric cancer in Western China.
    He X; Chen W; Tang D; Wen F; Zhang P; Li Q
    Eur J Cancer Care (Engl); 2019 May; 28(3):e13012. PubMed ID: 30748055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Racial differences in genomic testing and receipt of endocrine therapy in early-stage breast cancer.
    Ko NY; Qureshi MM; Oladeru OT; Cassidy MR; Oshry L; Truong MT; Hirsch AE
    Breast Cancer Res Treat; 2020 Dec; 184(3):849-859. PubMed ID: 32888137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved overall survival is still observed in patients receiving delayed adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Turner MC; Masoud SJ; Cerullo M; Adam MA; Shah KN; Blazer DG; Abbruzzese JL; Zani S
    HPB (Oxford); 2020 Nov; 22(11):1542-1548. PubMed ID: 32299656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
    Herskovic A; Mauer E; Christos P; Nagar H
    J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age as a prognostic indicator for adjuvant therapy in patients who underwent pancreatic resections for cancer.
    Eubanks A; Pepe J; Veldhuis P; de la Fuente SG
    J Geriatr Oncol; 2018 Jul; 9(4):362-366. PubMed ID: 29330039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
    Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.